Resolving Diagnostic Uncertainty

IMPORTANT INFORMATION

Specimens and Orders for PancraGEN® and Fluid Chemistry Testing Will Not Be Accepted After May 2, 2025.

Interpace will continue to offer ThyGeNEXT®+ThyraMIR®v2 testing for indeterminate thyroid nodules without interruption.

View Details

Visit Us at ENDO 2025 (Booth 1421) and WCTC 2025 (Booth 32)

Interpace Diagnostics

Interpace Diagnostics leverages the latest technology to develop and commercialize novel molecular diagnostic tests. Our tests are designed to detect genetic alterations that are associated with indeterminate thyroid nodule risk stratification and are principally focused on early detection and identification of high potential progression to cancer.

Identify the Best Course of Treatment

Our tests assist healthcare providers in distinguishing between patients at risk for progression to cancer versus non-progressions. Thus, as part of a comprehensive diagnostic and treatment plan, our tests allow healthcare providers to determine whether surgery or active surveillance is most appropriate.

Our molecular diagnostic products and services uniquely combine genomic technology, clinical science, and pathological review to provide answers that give physicians and patients a clear path forward and help avoid risky, costly surgeries that are often unnecessary.  Our experienced Molecular Pathologists provide multi-faceted reports that include treatment recommendations and algorithms based on the latest professional society guidelines.

Molecular Diagnostic Tests Currently Available

Product ThyGenX ThyraMIR
Indication Thyroid Cancer Thyroid Cancer
Diagnostic Test NGS Panel for Thyroid Cancer microRNA Risk Classifier for Thyroid Cancer
Diagnostic Report Rules In Thyroid Cancer Rules Out Thyroid Cancer

Detecting Cancer at the DNA Level

ThyGenNEXT® is an oncogenic mutation panel that helps identify malignant thyroid nodules.

ThyGenXLearn More

Increasing Preoperative Diagnostic Accuracy

ThyraMIR®v2 is a proprietary microRNA gene expression assay that helps to classify the risk of cancer in thyroid nodules.

ThyraMIRLearn More

How They Work


Learn More About Our Tests or Network of Distributors

Interpace has arrangements with distributors in ex-U.S. markets to make our products available to local physicians and hospitals.

Learn more about our distributors, our novel approach to molecular diagnostic testing, or inquire about our available diagnostic products by contacting us directly.

Get in Touch